Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Peptidoglycan Synthesis01:28

Peptidoglycan Synthesis

369
Structure of PeptidoglycanPeptidoglycan is a vital structural component of the bacterial cell wall, providing mechanical strength and shape to the cell. It consists of repeating units of two sugars—N-acetylglucosamine (NAG) and N-acetylmuramic acid (NAM)—linked by β-1,4 glycosidic bonds. These sugar chains are cross-linked by short peptide chains, forming a mesh-like polymer that surrounds the bacterial plasma membrane.Cytoplasmic Phase – Precursor SynthesisPeptidoglycan...
369
PPE Use in Healthcare Settings II: Doffing01:10

PPE Use in Healthcare Settings II: Doffing

1.1K
The sequence of removing or doffing PPE starts with the gloves, as they are the most contaminated. Next is removal of the face shield or goggles, as they would interfere with removing other PPE. Then remove the gown, followed by the mask or respirator. Perform hand hygiene between steps if hands become contaminated and immediately after removing all PPE. Generally, the outside front and sleeves of the isolation gown, the goggles or the mask, the respirator, and the face shield are contaminated.
1.1K
Prodrugs01:30

Prodrugs

2.8K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
2.8K
Drug Delivery: Overview01:16

Drug Delivery: Overview

411
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
411
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

249
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
249
Enlargement of the Plasma Membrane01:22

Enlargement of the Plasma Membrane

2.0K
Cell division and enlargement are processes that require precise control. The control ensures that cell division cannot proceed unless the cell has grown to a specific size. A spherical, dividing cell requires an approximately 1.6X increase in its surface area to double its volume. The secretory pathway also has a significant role in cell membrane enlargement. Secretory vesicles that bud off from the Golgi apparatus and later fuse with the plasma membrane during exocytosis are a major source of...
2.0K

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Injection Drug Use and Sexual Behaviors Associated With Infection Transmission and Access to Harm Reduction for People Who Use Drugs and Sell Sex in the Rural US.

Substance use : research and treatment·2026
Same author

Implementation Evaluation of a Multicomponent Intervention to Address the Infectious Disease and Overdose Syndemic Among People Who Use Drugs in Rural Settings.

Journal of public health management and practice : JPHMP·2026
Same author

Improving Anal Cancer Screening Messages Through Interviews From Men Who Have Sex With Men.

Health education & behavior : the official publication of the Society for Public Health Education·2026
Same author

Drug Use and Social Connectivity Related to Hepatitis C Infection Among Rural People Who Use Drugs.

Journal of viral hepatitis·2026
Same author

The safety and tolerability of oral TDF/FTC as pre-exposure prophylaxis among men who have sex with men in China: a prospective cohort study.

BMC infectious diseases·2026
Same author

Indirect Treatment Comparison of the Efficacy of Long-Acting Injectable Cabotegravir Compared With Lenacapavir for HIV Pre-exposure Prophylaxis.

Advances in therapy·2026

Video Experimental Relacionado

Updated: Sep 8, 2025

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles
09:56

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles

Published on: August 2, 2016

15.0K

DoxyPEP: Oportunidades de expansión

En-Ling Wu1, Jade Pagkas-Bather1, Aniruddha Hazra1

  • 1Department of Medicine, University of Chicago, Chicago, Illinois, USA.

Journal of primary care & community health
|September 6, 2025
PubMed
Resumen

La profilaxis posterior a la exposición a la doxiciclina (DoxyPEP) reduce significativamente las infecciones bacterianas de transmisión sexual (ITS) como la sífilis y la clamidia en poblaciones clave. Esta estrategia es prometedora para una prevención más amplia de las ITS frente a una epidemia en curso.

Palabras clave:
salud de la comunidadPrevención de la enfermedadCuidados primarioscomportamiento sexual arriesgadoDeterminantes sociales de la salud

Más Videos Relacionados

Imaging of Podocytic Proteins Nephrin, Actin, and Podocin with Expansion Microscopy
06:18

Imaging of Podocytic Proteins Nephrin, Actin, and Podocin with Expansion Microscopy

Published on: April 23, 2021

7.0K
Expansion and Enrichment of Gamma-Delta γδ T Cells from Apheresed Human Product
11:51

Expansion and Enrichment of Gamma-Delta γδ T Cells from Apheresed Human Product

Published on: September 22, 2021

9.2K

Videos de Experimentos Relacionados

Last Updated: Sep 8, 2025

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles
09:56

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles

Published on: August 2, 2016

15.0K
Imaging of Podocytic Proteins Nephrin, Actin, and Podocin with Expansion Microscopy
06:18

Imaging of Podocytic Proteins Nephrin, Actin, and Podocin with Expansion Microscopy

Published on: April 23, 2021

7.0K
Expansion and Enrichment of Gamma-Delta γδ T Cells from Apheresed Human Product
11:51

Expansion and Enrichment of Gamma-Delta γδ T Cells from Apheresed Human Product

Published on: September 22, 2021

9.2K

Área de la Ciencia:

  • Salud pública
  • Enfermedades infecciosas
  • Farmacología clínica

Sus antecedentes:

  • Las infecciones de transmisión sexual (ITS) siguen siendo una preocupación importante para la salud pública, con epidemias de infecciones bacterianas en curso.
  • Las estrategias de prevención actuales tienen limitaciones, lo que requiere nuevos enfoques para reducir la transmisión de ITS.
  • La profilaxis posterior a la exposición a la doxiciclina (DoxyPEP) ha surgido como una posible intervención.

Objetivo del estudio:

  • Evaluar la eficacia de la profilaxis post-exposición a la doxiciclina (DoxyPEP) en la reducción de la incidencia de las ITS bacterianas.
  • Revisar las directrices clínicas actuales y las estrategias de implementación práctica para DoxyPEP.
  • Explorar los beneficios potenciales de DoxyPEP para diversas poblaciones afectadas desproporcionadamente por las ITS.

Principales métodos:

  • Revisión de los datos de ensayos clínicos que demuestran el impacto de DoxyPEP en las tasas de ITS.
  • Análisis de datos del mundo real para evaluar la eficacia de DoxyPEP en varias poblaciones.
  • Síntesis de las directrices clínicas existentes y recomendaciones de expertos para el uso de DoxyPEP.

Principales resultados:

  • Los ensayos clínicos muestran que DoxyPEP reduce significativamente el riesgo de ITS bacterianas, en particular la sífilis y la clamidia.
  • El beneficio primario observado fue en hombres cisgénero que tienen relaciones sexuales con hombres y mujeres transgénero.
  • La evidencia del mundo real sugiere beneficios potenciales para otras poblaciones que enfrentan altas cargas de ITS.

Conclusiones:

  • DoxyPEP es una intervención muy eficaz para prevenir las ITS bacterianas en grupos específicos de alto riesgo.
  • La epidemia de ITS en curso justifica la discusión y la consideración de DoxyPEP para todos los pacientes elegibles.
  • La investigación adicional y la implementación estratégica son cruciales para maximizar el impacto de DoxyPEP en la salud pública.